Highly z-selective and enantioselective ring opening/cross metathesis catalyzed by a resolved stereogenic-at-ru complex

US2016101414A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016101414-A1
Application numberUS-201414890674-A
CountryUS
Kind codeA1
Filing dateMay 15, 2014
Priority dateMay 15, 2013
Publication dateApr 14, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This invention relates generally to enantiomerically enriched C—H activated ruthenium olefin metathesis catalyst compounds which are stereogenic at ruthenium, to the preparation of such compounds, and the use of such catalysts in the metathesis of olefins and olefin compounds, more particularly, in the use of such catalysts in enantio- and Z-selective olefin metathesis reactions. The invention has utility in the fields of catalysis, organic synthesis, polymer chemistry, and industrial and fine chemicals chemistry.

First claim

Opening claim text (preview).

The claimed invention is: 1 . An enantioenriched C—H activated catalyst compound having the structure of formula (II): wherein, M is a Group 8 transition metal; L 1 is a neutral electron donor ligand; Q* is a two electron anionic donor bridging moiety linking R 3 and M; Q is a linker selected from hydrocarbylene, substituted hydrocarbylene, heteroatom-containing hydrocarbylene, and substituted heteroatom-containing hydrocarbylene linkers; X is an atom selected from C, N, O, S, and P; R 1 and R 2 are independently selected from hydrogen, hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, and substituted heteroatom-containing, hydrocarbyl, and functional groups; R 3 and R 4 are independently selected from hydrogen, hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, and substituted heteroatom-containing, hydrocarbyl, and functional groups; n is zero, 1, or 2, such that n is zero when X is O or S, n is 1 when X is N or P, and n is 2 when X is C; and X 1 is a bidentate anionic ligand. 2 . An enantioenriched C—H activated catalyst compound, selected from 3 . A method, comprising: contacting an α-olefin with a strained olefin, in the presence of an enantioenriched C—H activated catalyst under conditions and for a time period effective to allow an asymmetric ring opening cross metathesis reaction to occur. 4 . The method of claim 3 , wherein the strained olefin is represented by the structure of formula (XIII): wherein R 13 is selected from the group consisting of hydrogen, hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, and substituted heteroatom-containing hydrocarbyl, wherein the substituents may be functional groups (“Fn”); and J is a saturated or unsaturated hydrocarbylene, substituted hydrocarbylene, heteroatom-containing hydrocarbylene, or substituted heteroatom-containing hydrocarbylene linkage, wherein when J is substituted hydrocarbylene or substituted heteroatom-containing hydrocarbylene, the substituents may include one or more —(Z) n -Fn groups, wherein n is zero or 1. 5 . The method of claim 4 , wherein the strained olefin is a mono-unsaturated cyclic olefin reactant. 6 . The method of claim 4 , wherein the strained olefin is a bicyclic olefinic reactant or a polycyclic olefinic reactant. 7 . The method of claim 3 , wherein the α-olefin is represented by the structure of formula (XVIII): wherein, Y α is selected from the group comprising nil, CH 2 , O, or S; and R α is selected from the group consisting of hydrogen, hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl and substituted heteroatom-containing hydrocarbyl wherein the substituents may be functional groups (“Fn”). 8 . The method of claim 3 , wherein the enantioenriched C—H activated catalyst has the structure of formula (II), wherein, M is a Group 8 transition metal; L 1 is a neutral electron donor ligand; Q* is a two electron anionic donor bridging moiety linking R 3 and M; Q is a linker selected from hydrocarbylene, substituted hydrocarbylene, heteroatom-containing hydrocarbylene, and substituted heteroatom-containing hydrocarbylene linkers; X is an atom selected from C, N, O, S, and P; R 1 and R 2 are independently selected from hydrogen, hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, and substituted heteroatom-containing, hydrocarbyl, and functional groups; R 3 and R 4 are independently selected from hydrogen, hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, and substituted heteroatom-containing, hydrocarbyl, and functional groups; n is zero, 1, or 2, such that n is zero when X is O or S, n is 1 when X is N or P, and n is 2 when X is C; and X 1 is a bidentate anionic ligand. 9 . An asymmetric ring opening cross metathesis product prepared by the method of claim 3 . 10 . An asymmetric ring opening cross metathesis product of claim 9 having a Z:E ratio greater than 1:1 in favor of the Z-isomer. 11 . An asymmetric ring opening cross metathesis product of claim 10 having an enantiomeric excess of greater than 50%. 12 . A method, comprising: reacting an α-olefin with a strained olefin, in the presence of an enantioenriched C—H activated catalyst, to form an asymmetric ring opening cross metathesis product with a Z:E ratio greater than 1:1 in favor of the Z-isomer. 13 . The method of claim 12 , wherein the asymmetric ring opening cross metathesis product is produced in an enantiomeric excess of greater than 50%.

Assignees

Inventors

Classifications

  • condensed with a ring other than six-membered · CPC title

  • by reactions not forming ether-oxygen bonds · CPC title

  • Preparation of esters of nitric acid · CPC title

  • by splitting of carbon-to-carbon bonds and redistribution, e.g. disproportionation or migration of [IMAGE cpc-sch-C07C-0963.gif] groups between different molecules · CPC title

  • Esters of boric acids · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016101414A1 cover?
This invention relates generally to enantiomerically enriched C—H activated ruthenium olefin metathesis catalyst compounds which are stereogenic at ruthenium, to the preparation of such compounds, and the use of such catalysts in the metathesis of olefins and olefin compounds, more particularly, in the use of such catalysts in enantio- and Z-selective olefin metathesis reactions. The invention …
Who is the assignee on this patent?
California Inst Of Techn
What technology area does this patent fall under?
Primary CPC classification B01J31/2278. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Thu Apr 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).